ATIVAN

This brand name is authorized in United States. It is also authorized in Ecuador, Estonia, Ireland, Malta, Mexico, New Zealand, South Africa, Turkey.

Active ingredients

The drug ATIVAN contains one active pharmaceutical ingredient (API):

1	Lorazepam UNII O26FZP769L - LORAZEPAM
	Lorazepam is a benzodiazepine with anxiolytic, sedative and hypnotic properties.
	Read more about Lorazepam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ATIVAN Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05BA06	Lorazepam	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02041413, 02041421, 02041448, 02041456, 02041464, 02041472
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.735-06-04, 25.884-08-04
EE	Ravimiamet	1092372
IE	Health Products Regulatory Authority	64106
MT	Medicines Authority	MA505/06101
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	75881
NZ	Medicines and Medical Devices Safety Authority	1590, 1594, 1595
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308011114, 8681308011121, 8681308011138, 8681308011145
US	FDA, National Drug Code	0187-0063, 0187-0064, 0187-0065, 0641-6000, 0641-6001, 0641-6002, 0641-6003
ZA	Health Products Regulatory Authority	JX/2.6/295, R/2.6/319